Guidelinevery high evidence
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation·April 28, 2026·PMID 41824552
Why it mattersThis guideline consolidates the latest evidence on lipid management, directly impacting how specialists assess cardiovascular risk, select therapies, and monitor patients with dyslipidemia. It replaces the 2018 guideline and integrates new data on emerging risk markers like lipoprotein(a) and novel lipid-lowering agents.

The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled